Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.3M Buy
3,690
+37
+1% +$13.2K 0.88% 33
2025
Q4
$1.2M Sell
3,653
-20
-0.5% -$6.34K 0.8% 34
2025
Q3
$1.04M Buy
3,673
+4
+0.1% +$1.16K 0.72% 40
2025
Q2
$1.02M Buy
3,669
+44
+1% +$12.5K 0.8% 39
2025
Q1
$1.13M Buy
3,625
+199
+6% +$58.8K 0.92% 33
2024
Q4
$893K Sell
3,426
-5
-0.1% -$1.48K 0.73% 42
2024
Q3
$1.11M Sell
3,431
-141
-4% -$46.1K 0.89% 34
2024
Q2
$1.12M Sell
3,572
-55
-2% -$16.2K 0.96% 33
2024
Q1
$1.03M Buy
3,627
+236
+7% +$69.1K 0.89% 38
2023
Q4
$977K Sell
3,391
-256
-7% -$69.8K 0.92% 34
2023
Q3
$980K Buy
3,647
+347
+11% +$86.6K 0.92% 35
2023
Q2
$733K Buy
3,300
+201
+6% +$46.6K 0.73% 47
2023
Q1
$758K Buy
3,099
+34
+1% +$8.35K 0.76% 42
2022
Q4
$802K Buy
3,065
+92
+3% +$24.7K 0.9% 35
2022
Q3
$685K Buy
2,973
+87
+3% +$21.1K 0.83% 37
2022
Q2
$705K Buy
2,886
+419
+17% +$103K 0.83% 37
2022
Q1
$618K Sell
2,467
-364
-13% -$83.6K 0.69% 46
2021
Q4
$634K Buy
+2,831
New +$598K 0.55% 57

Other funds holding AMGN

DMC Group's AMGN Position: Q1 2026 in Review

DMC Group increased its Amgen (AMGN) stake by 1% in Q1 2026, buying an estimated $13.2K and bringing the position to 3,690 shares worth $1.3M. The position accounts for 0.88% of the portfolio, ranked #33.

DMC Group first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • DMC Group held 3,690 shares of Amgen worth $1.3M as of Q1 2026.
  • DMC Group bought 37 Amgen shares in Q1 2026, an estimated $13.2K.
  • Amgen made up 0.88% of DMC Group's portfolio in Q1 2026, its #33 holding.
  • DMC Group first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on DMC Group's 13F filing for Q1 2026, filed 30 Apr 2026.